Drug
PTG-300
PTG-300 is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 6 completed trials
Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
17%(1 trials)
Phase Distribution
Ph phase_2
5
83%
Ph phase_1
1
17%
Phase Distribution
1
Early Stage
5
Mid Stage
0
Late Stage
Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
5(83.3%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
6 of 6 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(6)
Detailed Status
Completed6
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 11 (16.7%)
Phase 25 (83.3%)
Trials by Status
completed6100%
Recent Activity
0 active trials
Showing 5 of 6
completedphase_2
PTG-300 in Subjects With Hereditary Hemochromatosis
NCT04202965
completedphase_2
Hepcidin Mimetic in Patients With Polycythemia Vera (REVIVE)
NCT04057040
completedphase_2
PTG-300 in Patients With Polycythemia Vera and Elevated Hematocrit
NCT04767802
completedphase_1
Pharmacokinetics and Pharmacodynamics of Different PTG-300 Regimens in Healthy Volunteers
NCT04516382
completedphase_2
Safety Study for Beta Thalassemia Subjects on PTG-300
NCT04054921
Clinical Trials (6)
Showing 6 of 6 trials
NCT04202965Phase 2
PTG-300 in Subjects With Hereditary Hemochromatosis
NCT04057040Phase 2
Hepcidin Mimetic in Patients With Polycythemia Vera (REVIVE)
NCT04767802Phase 2
PTG-300 in Patients With Polycythemia Vera and Elevated Hematocrit
NCT04516382Phase 1
Pharmacokinetics and Pharmacodynamics of Different PTG-300 Regimens in Healthy Volunteers
NCT04054921Phase 2
Safety Study for Beta Thalassemia Subjects on PTG-300
NCT03802201Phase 2
Study of PTG-300 in Non-Transfusion Dependent and Transfusion-Dependent Beta-Thalassemia Subjects With Chronic Anemia
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6